{"transactions":[{"id":1870485,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":112846,"kind":"organization","name":"NBVM GP, LLC","position":1,"cik":"0001401650","reported_name":"NBVM GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46699,"kind":"person","name":"DAMORE RICHARD A","position":2,"cik":"0001206641","reported_name":"DAMORE RICHARD A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112847,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V A LP","position":3,"cik":"0001138402","reported_name":"NORTH BRIDGE VENTURE PARTNERS V A LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112848,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","position":4,"cik":"0001138399","reported_name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112849,"kind":"organization","name":"North Bridge Venture Partners VI L P","position":5,"cik":"0001327539","reported_name":"North Bridge Venture Partners VI L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112850,"kind":"organization","name":"North Bridge Venture Management V, L.P.","position":6,"cik":"0001297397","reported_name":"North Bridge Venture Management V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112851,"kind":"organization","name":"North Bridge Venture Management VI, L.P.","position":7,"cik":"0001590898","reported_name":"North Bridge Venture Management VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant to purchase Common Stock","published_at":"2023-06-02T16:15:21.000Z","date":"2023-05-31","kind":"purchase","planned":false,"acquired":true,"shares":601806,"price":0.125,"value":75225.75,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reportable securities were acquired pursuant to the Securities Purchase Agreement dated May 25, 2023 between the Issuer, North Bridge Venture Partners V-A, L.P. (\"NBVP V-A\"), North Bridge Venture Partners V-B, L.P. (\"NBVP V-B\"), North Bridge Venture Partners VI, L.P. (\"NBVP VI\") and certain other investors."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reportable securities are owned directly by NBVP VI. North Bridge Venture Management VI, L.P. (\"NBVM VI\") is the sole general partner of NBVP VI and NBVM GP is the sole general partner of NBVM VI. Each of Anderson, a member of the Issuer's board of directors, and D'Amore are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP VI. Each of NBVM VI, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":601806,"derivative":{"exercise_price":2.673,"exercise_date":"2023-11-30","expiration_date":"2028-11-30","underlying":"Common Stock","underlying_shares":601806},"source":{"system":"sec-edgar","filing":"0000899243-23-014352","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1138402/000089924323014352/doc4.xml","form_type":"4"}},{"id":1870484,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":112846,"kind":"organization","name":"NBVM GP, LLC","position":1,"cik":"0001401650","reported_name":"NBVM GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46699,"kind":"person","name":"DAMORE RICHARD A","position":2,"cik":"0001206641","reported_name":"DAMORE RICHARD A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112847,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V A LP","position":3,"cik":"0001138402","reported_name":"NORTH BRIDGE VENTURE PARTNERS V A LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112848,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","position":4,"cik":"0001138399","reported_name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112849,"kind":"organization","name":"North Bridge Venture Partners VI L P","position":5,"cik":"0001327539","reported_name":"North Bridge Venture Partners VI L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112850,"kind":"organization","name":"North Bridge Venture Management V, L.P.","position":6,"cik":"0001297397","reported_name":"North Bridge Venture Management V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112851,"kind":"organization","name":"North Bridge Venture Management VI, L.P.","position":7,"cik":"0001590898","reported_name":"North Bridge Venture Management VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant to purchase Common Stock","published_at":"2023-06-02T16:15:21.000Z","date":"2023-05-31","kind":"purchase","planned":false,"acquired":true,"shares":98973,"price":0.125,"value":12371.625,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reportable securities were acquired pursuant to the Securities Purchase Agreement dated May 25, 2023 between the Issuer, North Bridge Venture Partners V-A, L.P. (\"NBVP V-A\"), North Bridge Venture Partners V-B, L.P. (\"NBVP V-B\"), North Bridge Venture Partners VI, L.P. (\"NBVP VI\") and certain other investors."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reportable securities are owned directly by NBVP V-B. NBVM V is the sole general partner of NBVP V-B and NBVM GP is the sole general partner of NBVM V. Each of Anderson, a member of the Issuer's board of directors, and D'Amore are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP V-B. Each of NBVM V, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":98973,"derivative":{"exercise_price":2.673,"exercise_date":"2023-11-30","expiration_date":"2028-11-30","underlying":"Common Stock","underlying_shares":98973},"source":{"system":"sec-edgar","filing":"0000899243-23-014352","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1138402/000089924323014352/doc4.xml","form_type":"4"}},{"id":1870483,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":112846,"kind":"organization","name":"NBVM GP, LLC","position":1,"cik":"0001401650","reported_name":"NBVM GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46699,"kind":"person","name":"DAMORE RICHARD A","position":2,"cik":"0001206641","reported_name":"DAMORE RICHARD A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112847,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V A LP","position":3,"cik":"0001138402","reported_name":"NORTH BRIDGE VENTURE PARTNERS V A LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112848,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","position":4,"cik":"0001138399","reported_name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112849,"kind":"organization","name":"North Bridge Venture Partners VI L P","position":5,"cik":"0001327539","reported_name":"North Bridge Venture Partners VI L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112850,"kind":"organization","name":"North Bridge Venture Management V, L.P.","position":6,"cik":"0001297397","reported_name":"North Bridge Venture Management V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112851,"kind":"organization","name":"North Bridge Venture Management VI, L.P.","position":7,"cik":"0001590898","reported_name":"North Bridge Venture Management VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant to purchase Common Stock","published_at":"2023-06-02T16:15:21.000Z","date":"2023-05-31","kind":"purchase","planned":false,"acquired":true,"shares":201929,"price":0.125,"value":25241.125,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reportable securities were acquired pursuant to the Securities Purchase Agreement dated May 25, 2023 between the Issuer, North Bridge Venture Partners V-A, L.P. (\"NBVP V-A\"), North Bridge Venture Partners V-B, L.P. (\"NBVP V-B\"), North Bridge Venture Partners VI, L.P. (\"NBVP VI\") and certain other investors."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reportable securities are owned directly by NBVP V-A. North Bridge Venture Management V, L.P. (\"NBVM V\") is the sole general partner of NBVP V-A and North Bridge Venture Management GP, LLC (\"NBVM GP\") is the sole general partner of NBVM V. Each of Edward T. Anderson (\"Anderson\"), a member of the Issuer's board of directors, and Richard A. D'Amore (\"D'Amore\") are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP V-A. Each of NBVM V, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":201929,"derivative":{"exercise_price":2.673,"exercise_date":"2023-11-30","expiration_date":"2028-11-30","underlying":"Common Stock","underlying_shares":201929},"source":{"system":"sec-edgar","filing":"0000899243-23-014352","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1138402/000089924323014352/doc4.xml","form_type":"4"}},{"id":1870482,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":112846,"kind":"organization","name":"NBVM GP, LLC","position":1,"cik":"0001401650","reported_name":"NBVM GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46699,"kind":"person","name":"DAMORE RICHARD A","position":2,"cik":"0001206641","reported_name":"DAMORE RICHARD A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112847,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V A LP","position":3,"cik":"0001138402","reported_name":"NORTH BRIDGE VENTURE PARTNERS V A LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112848,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","position":4,"cik":"0001138399","reported_name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112849,"kind":"organization","name":"North Bridge Venture Partners VI L P","position":5,"cik":"0001327539","reported_name":"North Bridge Venture Partners VI L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112850,"kind":"organization","name":"North Bridge Venture Management V, L.P.","position":6,"cik":"0001297397","reported_name":"North Bridge Venture Management V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112851,"kind":"organization","name":"North Bridge Venture Management VI, L.P.","position":7,"cik":"0001590898","reported_name":"North Bridge Venture Management VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-06-02T16:15:21.000Z","date":"2023-05-31","kind":"purchase","planned":false,"acquired":true,"shares":1203612,"price":2.43,"value":2924777.16,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reportable securities were acquired pursuant to the Securities Purchase Agreement dated May 25, 2023 between the Issuer, North Bridge Venture Partners V-A, L.P. (\"NBVP V-A\"), North Bridge Venture Partners V-B, L.P. (\"NBVP V-B\"), North Bridge Venture Partners VI, L.P. (\"NBVP VI\") and certain other investors."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reportable securities are owned directly by NBVP VI. North Bridge Venture Management VI, L.P. (\"NBVM VI\") is the sole general partner of NBVP VI and NBVM GP is the sole general partner of NBVM VI. Each of Anderson, a member of the Issuer's board of directors, and D'Amore are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP VI. Each of NBVM VI, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":2521745,"source":{"system":"sec-edgar","filing":"0000899243-23-014352","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1138402/000089924323014352/doc4.xml","form_type":"4"}},{"id":1870481,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":112846,"kind":"organization","name":"NBVM GP, LLC","position":1,"cik":"0001401650","reported_name":"NBVM GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46699,"kind":"person","name":"DAMORE RICHARD A","position":2,"cik":"0001206641","reported_name":"DAMORE RICHARD A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112847,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V A LP","position":3,"cik":"0001138402","reported_name":"NORTH BRIDGE VENTURE PARTNERS V A LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112848,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","position":4,"cik":"0001138399","reported_name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112849,"kind":"organization","name":"North Bridge Venture Partners VI L P","position":5,"cik":"0001327539","reported_name":"North Bridge Venture Partners VI L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112850,"kind":"organization","name":"North Bridge Venture Management V, L.P.","position":6,"cik":"0001297397","reported_name":"North Bridge Venture Management V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112851,"kind":"organization","name":"North Bridge Venture Management VI, L.P.","position":7,"cik":"0001590898","reported_name":"North Bridge Venture Management VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-06-02T16:15:21.000Z","date":"2023-05-31","kind":"purchase","planned":false,"acquired":true,"shares":197946,"price":2.43,"value":481008.78,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reportable securities were acquired pursuant to the Securities Purchase Agreement dated May 25, 2023 between the Issuer, North Bridge Venture Partners V-A, L.P. (\"NBVP V-A\"), North Bridge Venture Partners V-B, L.P. (\"NBVP V-B\"), North Bridge Venture Partners VI, L.P. (\"NBVP VI\") and certain other investors."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reportable securities are owned directly by NBVP V-B. NBVM V is the sole general partner of NBVP V-B and NBVM GP is the sole general partner of NBVM V. Each of Anderson, a member of the Issuer's board of directors, and D'Amore are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP V-B. Each of NBVM V, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":1107370,"source":{"system":"sec-edgar","filing":"0000899243-23-014352","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1138402/000089924323014352/doc4.xml","form_type":"4"}},{"id":1870480,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":112846,"kind":"organization","name":"NBVM GP, LLC","position":1,"cik":"0001401650","reported_name":"NBVM GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46699,"kind":"person","name":"DAMORE RICHARD A","position":2,"cik":"0001206641","reported_name":"DAMORE RICHARD A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112847,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V A LP","position":3,"cik":"0001138402","reported_name":"NORTH BRIDGE VENTURE PARTNERS V A LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112848,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","position":4,"cik":"0001138399","reported_name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112849,"kind":"organization","name":"North Bridge Venture Partners VI L P","position":5,"cik":"0001327539","reported_name":"North Bridge Venture Partners VI L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112850,"kind":"organization","name":"North Bridge Venture Management V, L.P.","position":6,"cik":"0001297397","reported_name":"North Bridge Venture Management V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112851,"kind":"organization","name":"North Bridge Venture Management VI, L.P.","position":7,"cik":"0001590898","reported_name":"North Bridge Venture Management VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-06-02T16:15:21.000Z","date":"2023-05-31","kind":"purchase","planned":false,"acquired":true,"shares":403858,"price":2.43,"value":981374.94,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reportable securities were acquired pursuant to the Securities Purchase Agreement dated May 25, 2023 between the Issuer, North Bridge Venture Partners V-A, L.P. (\"NBVP V-A\"), North Bridge Venture Partners V-B, L.P. (\"NBVP V-B\"), North Bridge Venture Partners VI, L.P. (\"NBVP VI\") and certain other investors."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reportable securities are owned directly by NBVP V-A. North Bridge Venture Management V, L.P. (\"NBVM V\") is the sole general partner of NBVP V-A and North Bridge Venture Management GP, LLC (\"NBVM GP\") is the sole general partner of NBVM V. Each of Edward T. Anderson (\"Anderson\"), a member of the Issuer's board of directors, and Richard A. D'Amore (\"D'Amore\") are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP V-A. Each of NBVM V, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":2259301,"source":{"system":"sec-edgar","filing":"0000899243-23-014352","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1138402/000089924323014352/doc4.xml","form_type":"4"}},{"id":2297111,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":112846,"kind":"organization","name":"NBVM GP, LLC","position":1,"cik":"0001401650","reported_name":"NBVM GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46699,"kind":"person","name":"DAMORE RICHARD A","position":2,"cik":"0001206641","reported_name":"DAMORE RICHARD A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112847,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V A LP","position":3,"cik":"0001138402","reported_name":"NORTH BRIDGE VENTURE PARTNERS V A LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112848,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","position":4,"cik":"0001138399","reported_name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112849,"kind":"organization","name":"North Bridge Venture Partners VI L P","position":5,"cik":"0001327539","reported_name":"North Bridge Venture Partners VI L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112850,"kind":"organization","name":"North Bridge Venture Management V, L.P.","position":6,"cik":"0001297397","reported_name":"North Bridge Venture Management V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112851,"kind":"organization","name":"North Bridge Venture Management VI, L.P.","position":7,"cik":"0001590898","reported_name":"North Bridge Venture Management VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-04-14T16:14:26.000Z","date":"2022-04-12","kind":"purchase","acquired":true,"shares":765010,"price":4.22,"value":3228342.2,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reportable securities were acquired pursuant to the Securities Purchase Agreement dated April 7, 2022 between the Issuer, North Bridge Venture Partners V-A, L.P. (\"NBVP V-A\"), North Bridge Venture Partners V-B, L.P. (\"NBVP V-B\"), North Bridge Venture Partners VI, L.P. (\"NBVP VI\") and certain other investors."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reportable securities are owned directly by NBVP VI. North Bridge Venture Management VI, L.P. (\"NBVM VI\") is the sole general partner of NBVP VI and NBVM GP is the sole general partner of NBVM VI. Each of Anderson, a member of the Issuer's board of directors, and D'Amore are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP VI. Each of NBVM VI, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":1318133,"source":{"system":"sec-edgar","filing":"0000899243-22-014796","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1138402/000089924322014796/doc4.xml","form_type":"4"}},{"id":2297110,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":112846,"kind":"organization","name":"NBVM GP, LLC","position":1,"cik":"0001401650","reported_name":"NBVM GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46699,"kind":"person","name":"DAMORE RICHARD A","position":2,"cik":"0001206641","reported_name":"DAMORE RICHARD A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112847,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V A LP","position":3,"cik":"0001138402","reported_name":"NORTH BRIDGE VENTURE PARTNERS V A LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112848,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","position":4,"cik":"0001138399","reported_name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112849,"kind":"organization","name":"North Bridge Venture Partners VI L P","position":5,"cik":"0001327539","reported_name":"North Bridge Venture Partners VI L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112850,"kind":"organization","name":"North Bridge Venture Management V, L.P.","position":6,"cik":"0001297397","reported_name":"North Bridge Venture Management V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112851,"kind":"organization","name":"North Bridge Venture Management VI, L.P.","position":7,"cik":"0001590898","reported_name":"North Bridge Venture Management VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-04-14T16:14:26.000Z","date":"2022-04-12","kind":"purchase","acquired":true,"shares":527806,"price":4.22,"value":2227341.32,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reportable securities were acquired pursuant to the Securities Purchase Agreement dated April 7, 2022 between the Issuer, North Bridge Venture Partners V-A, L.P. (\"NBVP V-A\"), North Bridge Venture Partners V-B, L.P. (\"NBVP V-B\"), North Bridge Venture Partners VI, L.P. (\"NBVP VI\") and certain other investors."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reportable securities are owned directly by NBVP V-B. NBVM V is the sole general partner of NBVP V-B and NBVM GP is the sole general partner of NBVM V. Each of Anderson, a member of the Issuer's board of directors, and D'Amore are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP V-B. Each of NBVM V, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":909424,"source":{"system":"sec-edgar","filing":"0000899243-22-014796","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1138402/000089924322014796/doc4.xml","form_type":"4"}},{"id":2297109,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":112846,"kind":"organization","name":"NBVM GP, LLC","position":1,"cik":"0001401650","reported_name":"NBVM GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46699,"kind":"person","name":"DAMORE RICHARD A","position":2,"cik":"0001206641","reported_name":"DAMORE RICHARD A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112847,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V A LP","position":3,"cik":"0001138402","reported_name":"NORTH BRIDGE VENTURE PARTNERS V A LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112848,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","position":4,"cik":"0001138399","reported_name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112849,"kind":"organization","name":"North Bridge Venture Partners VI L P","position":5,"cik":"0001327539","reported_name":"North Bridge Venture Partners VI L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112850,"kind":"organization","name":"North Bridge Venture Management V, L.P.","position":6,"cik":"0001297397","reported_name":"North Bridge Venture Management V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112851,"kind":"organization","name":"North Bridge Venture Management VI, L.P.","position":7,"cik":"0001590898","reported_name":"North Bridge Venture Management VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-04-14T16:14:26.000Z","date":"2022-04-12","kind":"purchase","acquired":true,"shares":1076851,"price":4.22,"value":4544311.22,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reportable securities were acquired pursuant to the Securities Purchase Agreement dated April 7, 2022 between the Issuer, North Bridge Venture Partners V-A, L.P. (\"NBVP V-A\"), North Bridge Venture Partners V-B, L.P. (\"NBVP V-B\"), North Bridge Venture Partners VI, L.P. (\"NBVP VI\") and certain other investors."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reportable securities are owned directly by NBVP V-A. North Bridge Venture Management V, L.P. (\"NBVM V\") is the sole general partner of NBVP V-A and North Bridge Venture Management GP, LLC (\"NBVM GP\") is the sole general partner of NBVM V. Each of Edward T. Anderson (\"Anderson\"), a member of the Issuer's board of directors, and Richard A. D'Amore (\"D'Amore\") are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP V-A. Each of NBVM V, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":1855443,"source":{"system":"sec-edgar","filing":"0000899243-22-014796","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1138402/000089924322014796/doc4.xml","form_type":"4"}},{"id":3159789,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":112846,"kind":"organization","name":"NBVM GP, LLC","position":1,"cik":"0001401650","reported_name":"NBVM GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46699,"kind":"person","name":"DAMORE RICHARD A","position":2,"cik":"0001206641","reported_name":"DAMORE RICHARD A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112847,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V A LP","position":3,"cik":"0001138402","reported_name":"NORTH BRIDGE VENTURE PARTNERS V A LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112848,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","position":4,"cik":"0001138399","reported_name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112849,"kind":"organization","name":"North Bridge Venture Partners VI L P","position":5,"cik":"0001327539","reported_name":"North Bridge Venture Partners VI L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112850,"kind":"organization","name":"North Bridge Venture Management V, L.P.","position":6,"cik":"0001297397","reported_name":"North Bridge Venture Management V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112851,"kind":"organization","name":"North Bridge Venture Management VI, L.P.","position":7,"cik":"0001590898","reported_name":"North Bridge Venture Management VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Warrants","published_at":"2020-05-06T19:38:21.000Z","date":"2020-05-05","kind":"other","acquired":false,"shares":13449,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reportable securities are owned directly by North Bridge Venture Partners VI, L.P. (\"NBVP VI\"). North Bridge Venture Management VI, L.P. (\"NBVM VI\") is the sole general partner of NBVP VI and NBVM GP is the sole general partner of NBVM VI. Each of Anderson, a member of the Issuer's board of directors, and D'Amore are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP VI. Each of NBVM VI, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"exercise_price":8.63,"exercise_date":"2020-01-17","expiration_date":"2030-01-10","underlying":"Common Stock","underlying_shares":13449},"source":{"system":"sec-edgar","filing":"0000899243-20-012179","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":39,"url":"https://www.sec.gov/Archives/edgar/data/1138402/000089924320012179/doc4.xml","form_type":"4"}},{"id":3159788,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":112846,"kind":"organization","name":"NBVM GP, LLC","position":1,"cik":"0001401650","reported_name":"NBVM GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46699,"kind":"person","name":"DAMORE RICHARD A","position":2,"cik":"0001206641","reported_name":"DAMORE RICHARD A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112847,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V A LP","position":3,"cik":"0001138402","reported_name":"NORTH BRIDGE VENTURE PARTNERS V A LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112848,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","position":4,"cik":"0001138399","reported_name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112849,"kind":"organization","name":"North Bridge Venture Partners VI L P","position":5,"cik":"0001327539","reported_name":"North Bridge Venture Partners VI L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112850,"kind":"organization","name":"North Bridge Venture Management V, L.P.","position":6,"cik":"0001297397","reported_name":"North Bridge Venture Management V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112851,"kind":"organization","name":"North Bridge Venture Management VI, L.P.","position":7,"cik":"0001590898","reported_name":"North Bridge Venture Management VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Warrants","published_at":"2020-05-06T19:38:21.000Z","date":"2020-05-05","kind":"other","acquired":false,"shares":10322,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reportable securities are owned directly by North Bridge Venture Partners V-B, L.P. (\"NBVP V-B\"). NBVM V is the sole general partner of NBVP V-B and NBVM GP is the sole general partner of NBVM V. Each of Anderson, a member of the Issuer's board of directors, and D'Amore are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP V-B. Each of NBVM V, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"exercise_price":8.63,"exercise_date":"2020-01-17","expiration_date":"2030-01-10","underlying":"Common Stock","underlying_shares":10322},"source":{"system":"sec-edgar","filing":"0000899243-20-012179","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":38,"url":"https://www.sec.gov/Archives/edgar/data/1138402/000089924320012179/doc4.xml","form_type":"4"}},{"id":3159787,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":112846,"kind":"organization","name":"NBVM GP, LLC","position":1,"cik":"0001401650","reported_name":"NBVM GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46699,"kind":"person","name":"DAMORE RICHARD A","position":2,"cik":"0001206641","reported_name":"DAMORE RICHARD A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112847,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V A LP","position":3,"cik":"0001138402","reported_name":"NORTH BRIDGE VENTURE PARTNERS V A LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112848,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","position":4,"cik":"0001138399","reported_name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112849,"kind":"organization","name":"North Bridge Venture Partners VI L P","position":5,"cik":"0001327539","reported_name":"North Bridge Venture Partners VI L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112850,"kind":"organization","name":"North Bridge Venture Management V, L.P.","position":6,"cik":"0001297397","reported_name":"North Bridge Venture Management V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112851,"kind":"organization","name":"North Bridge Venture Management VI, L.P.","position":7,"cik":"0001590898","reported_name":"North Bridge Venture Management VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Warrants","published_at":"2020-05-06T19:38:21.000Z","date":"2020-05-05","kind":"other","acquired":false,"shares":21060,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reportable securities are owned directly by North Bridge Venture Partners V-A, L.P. (\"NBVP V-A\"). North Bridge Venture Management V, L.P. (\"NBVM V\") is the sole general partner of NBVP V-A and North Bridge Venture Management GP, LLC (\"NBVM GP\") is the sole general partner of NBVM V. Each of Edward T. Anderson (\"Anderson\"), a member of the Issuer's board of directors, and Richard A. D'Amore (\"D'Amore\") are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP V-A. Each of NBVM V, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"exercise_price":8.63,"exercise_date":"2020-01-17","expiration_date":"2030-01-10","underlying":"Common Stock","underlying_shares":21060},"source":{"system":"sec-edgar","filing":"0000899243-20-012179","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":37,"url":"https://www.sec.gov/Archives/edgar/data/1138402/000089924320012179/doc4.xml","form_type":"4"}},{"id":3159786,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":112846,"kind":"organization","name":"NBVM GP, LLC","position":1,"cik":"0001401650","reported_name":"NBVM GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46699,"kind":"person","name":"DAMORE RICHARD A","position":2,"cik":"0001206641","reported_name":"DAMORE RICHARD A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112847,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V A LP","position":3,"cik":"0001138402","reported_name":"NORTH BRIDGE VENTURE PARTNERS V A LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112848,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","position":4,"cik":"0001138399","reported_name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112849,"kind":"organization","name":"North Bridge Venture Partners VI L P","position":5,"cik":"0001327539","reported_name":"North Bridge Venture Partners VI L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112850,"kind":"organization","name":"North Bridge Venture Management V, L.P.","position":6,"cik":"0001297397","reported_name":"North Bridge Venture Management V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112851,"kind":"organization","name":"North Bridge Venture Management VI, L.P.","position":7,"cik":"0001590898","reported_name":"North Bridge Venture Management VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2020-05-06T19:38:21.000Z","date":"2020-05-05","kind":"exercise","acquired":false,"shares":1545953,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reportable securities are owned directly by North Bridge Venture Partners VI, L.P. (\"NBVP VI\"). North Bridge Venture Management VI, L.P. (\"NBVM VI\") is the sole general partner of NBVP VI and NBVM GP is the sole general partner of NBVM VI. Each of Anderson, a member of the Issuer's board of directors, and D'Amore are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP VI. Each of NBVM VI, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":44832},"source":{"system":"sec-edgar","filing":"0000899243-20-012179","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":36,"url":"https://www.sec.gov/Archives/edgar/data/1138402/000089924320012179/doc4.xml","form_type":"4"}},{"id":3159785,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":112846,"kind":"organization","name":"NBVM GP, LLC","position":1,"cik":"0001401650","reported_name":"NBVM GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46699,"kind":"person","name":"DAMORE RICHARD A","position":2,"cik":"0001206641","reported_name":"DAMORE RICHARD A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112847,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V A LP","position":3,"cik":"0001138402","reported_name":"NORTH BRIDGE VENTURE PARTNERS V A LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112848,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","position":4,"cik":"0001138399","reported_name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112849,"kind":"organization","name":"North Bridge Venture Partners VI L P","position":5,"cik":"0001327539","reported_name":"North Bridge Venture Partners VI L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112850,"kind":"organization","name":"North Bridge Venture Management V, L.P.","position":6,"cik":"0001297397","reported_name":"North Bridge Venture Management V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112851,"kind":"organization","name":"North Bridge Venture Management VI, L.P.","position":7,"cik":"0001590898","reported_name":"North Bridge Venture Management VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2020-05-06T19:38:21.000Z","date":"2020-05-05","kind":"exercise","acquired":false,"shares":1186496,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reportable securities are owned directly by North Bridge Venture Partners V-B, L.P. (\"NBVP V-B\"). NBVM V is the sole general partner of NBVP V-B and NBVM GP is the sole general partner of NBVM V. Each of Anderson, a member of the Issuer's board of directors, and D'Amore are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP V-B. Each of NBVM V, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":34408},"source":{"system":"sec-edgar","filing":"0000899243-20-012179","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":35,"url":"https://www.sec.gov/Archives/edgar/data/1138402/000089924320012179/doc4.xml","form_type":"4"}},{"id":3159784,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":112846,"kind":"organization","name":"NBVM GP, LLC","position":1,"cik":"0001401650","reported_name":"NBVM GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46699,"kind":"person","name":"DAMORE RICHARD A","position":2,"cik":"0001206641","reported_name":"DAMORE RICHARD A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112847,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V A LP","position":3,"cik":"0001138402","reported_name":"NORTH BRIDGE VENTURE PARTNERS V A LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112848,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","position":4,"cik":"0001138399","reported_name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112849,"kind":"organization","name":"North Bridge Venture Partners VI L P","position":5,"cik":"0001327539","reported_name":"North Bridge Venture Partners VI L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112850,"kind":"organization","name":"North Bridge Venture Management V, L.P.","position":6,"cik":"0001297397","reported_name":"North Bridge Venture Management V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112851,"kind":"organization","name":"North Bridge Venture Management VI, L.P.","position":7,"cik":"0001590898","reported_name":"North Bridge Venture Management VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2020-05-06T19:38:21.000Z","date":"2020-05-05","kind":"exercise","acquired":false,"shares":2420729,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reportable securities are owned directly by North Bridge Venture Partners V-A, L.P. (\"NBVP V-A\"). North Bridge Venture Management V, L.P. (\"NBVM V\") is the sole general partner of NBVP V-A and North Bridge Venture Management GP, LLC (\"NBVM GP\") is the sole general partner of NBVM V. Each of Edward T. Anderson (\"Anderson\"), a member of the Issuer's board of directors, and Richard A. D'Amore (\"D'Amore\") are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP V-A. Each of NBVM V, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":70200},"source":{"system":"sec-edgar","filing":"0000899243-20-012179","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":34,"url":"https://www.sec.gov/Archives/edgar/data/1138402/000089924320012179/doc4.xml","form_type":"4"}},{"id":3159783,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":112846,"kind":"organization","name":"NBVM GP, LLC","position":1,"cik":"0001401650","reported_name":"NBVM GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46699,"kind":"person","name":"DAMORE RICHARD A","position":2,"cik":"0001206641","reported_name":"DAMORE RICHARD A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112847,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V A LP","position":3,"cik":"0001138402","reported_name":"NORTH BRIDGE VENTURE PARTNERS V A LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112848,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","position":4,"cik":"0001138399","reported_name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112849,"kind":"organization","name":"North Bridge Venture Partners VI L P","position":5,"cik":"0001327539","reported_name":"North Bridge Venture Partners VI L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112850,"kind":"organization","name":"North Bridge Venture Management V, L.P.","position":6,"cik":"0001297397","reported_name":"North Bridge Venture Management V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112851,"kind":"organization","name":"North Bridge Venture Management VI, L.P.","position":7,"cik":"0001590898","reported_name":"North Bridge Venture Management VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2020-05-06T19:38:21.000Z","date":"2020-05-05","kind":"exercise","acquired":false,"shares":1995489,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reportable securities are owned directly by North Bridge Venture Partners VI, L.P. (\"NBVP VI\"). North Bridge Venture Management VI, L.P. (\"NBVM VI\") is the sole general partner of NBVP VI and NBVM GP is the sole general partner of NBVM VI. Each of Anderson, a member of the Issuer's board of directors, and D'Amore are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP VI. Each of NBVM VI, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":57868},"source":{"system":"sec-edgar","filing":"0000899243-20-012179","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":33,"url":"https://www.sec.gov/Archives/edgar/data/1138402/000089924320012179/doc4.xml","form_type":"4"}},{"id":3159782,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":112846,"kind":"organization","name":"NBVM GP, LLC","position":1,"cik":"0001401650","reported_name":"NBVM GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46699,"kind":"person","name":"DAMORE RICHARD A","position":2,"cik":"0001206641","reported_name":"DAMORE RICHARD A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112847,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V A LP","position":3,"cik":"0001138402","reported_name":"NORTH BRIDGE VENTURE PARTNERS V A LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112848,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","position":4,"cik":"0001138399","reported_name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112849,"kind":"organization","name":"North Bridge Venture Partners VI L P","position":5,"cik":"0001327539","reported_name":"North Bridge Venture Partners VI L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112850,"kind":"organization","name":"North Bridge Venture Management V, L.P.","position":6,"cik":"0001297397","reported_name":"North Bridge Venture Management V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112851,"kind":"organization","name":"North Bridge Venture Management VI, L.P.","position":7,"cik":"0001590898","reported_name":"North Bridge Venture Management VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2020-05-06T19:38:21.000Z","date":"2020-05-05","kind":"exercise","acquired":false,"shares":1531507,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"On May 5, 2020, NBVP VI exercised a warrant to purchase 13,449 shares of the Issuer's common stock for $16.00 a share, which represents the Issuer's initial public offering price. In connection with the automatic net exercise of the warrant immediately prior to the closing of the Issuer's initial public offering, the Issuer withheld 7,255 of the warrant shares to pay the exercise price and issued the remaining warrant shares to NBVP VI. The Issuer also paid $15.13 to NBVP VI in lieu of a fractional share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reportable securities are owned directly by North Bridge Venture Partners V-B, L.P. (\"NBVP V-B\"). NBVM V is the sole general partner of NBVP V-B and NBVM GP is the sole general partner of NBVM V. Each of Anderson, a member of the Issuer's board of directors, and D'Amore are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP V-B. Each of NBVM V, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":44413},"source":{"system":"sec-edgar","filing":"0000899243-20-012179","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":32,"url":"https://www.sec.gov/Archives/edgar/data/1138402/000089924320012179/doc4.xml","form_type":"4"}},{"id":3159781,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":112846,"kind":"organization","name":"NBVM GP, LLC","position":1,"cik":"0001401650","reported_name":"NBVM GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46699,"kind":"person","name":"DAMORE RICHARD A","position":2,"cik":"0001206641","reported_name":"DAMORE RICHARD A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112847,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V A LP","position":3,"cik":"0001138402","reported_name":"NORTH BRIDGE VENTURE PARTNERS V A LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112848,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","position":4,"cik":"0001138399","reported_name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112849,"kind":"organization","name":"North Bridge Venture Partners VI L P","position":5,"cik":"0001327539","reported_name":"North Bridge Venture Partners VI L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112850,"kind":"organization","name":"North Bridge Venture Management V, L.P.","position":6,"cik":"0001297397","reported_name":"North Bridge Venture Management V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112851,"kind":"organization","name":"North Bridge Venture Management VI, L.P.","position":7,"cik":"0001590898","reported_name":"North Bridge Venture Management VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2020-05-06T19:38:21.000Z","date":"2020-05-05","kind":"exercise","acquired":false,"shares":3124633,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reportable securities are owned directly by North Bridge Venture Partners V-A, L.P. (\"NBVP V-A\"). North Bridge Venture Management V, L.P. (\"NBVM V\") is the sole general partner of NBVP V-A and North Bridge Venture Management GP, LLC (\"NBVM GP\") is the sole general partner of NBVM V. Each of Edward T. Anderson (\"Anderson\"), a member of the Issuer's board of directors, and Richard A. D'Amore (\"D'Amore\") are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP V-A. Each of NBVM V, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":90613},"source":{"system":"sec-edgar","filing":"0000899243-20-012179","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":31,"url":"https://www.sec.gov/Archives/edgar/data/1138402/000089924320012179/doc4.xml","form_type":"4"}},{"id":3159780,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":112846,"kind":"organization","name":"NBVM GP, LLC","position":1,"cik":"0001401650","reported_name":"NBVM GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46699,"kind":"person","name":"DAMORE RICHARD A","position":2,"cik":"0001206641","reported_name":"DAMORE RICHARD A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112847,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V A LP","position":3,"cik":"0001138402","reported_name":"NORTH BRIDGE VENTURE PARTNERS V A LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112848,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","position":4,"cik":"0001138399","reported_name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112849,"kind":"organization","name":"North Bridge Venture Partners VI L P","position":5,"cik":"0001327539","reported_name":"North Bridge Venture Partners VI L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112850,"kind":"organization","name":"North Bridge Venture Management V, L.P.","position":6,"cik":"0001297397","reported_name":"North Bridge Venture Management V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112851,"kind":"organization","name":"North Bridge Venture Management VI, L.P.","position":7,"cik":"0001590898","reported_name":"North Bridge Venture Management VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-4 Convertible Preferred Stock","published_at":"2020-05-06T19:38:21.000Z","date":"2020-05-05","kind":"exercise","acquired":false,"shares":2391895,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reportable securities are owned directly by North Bridge Venture Partners VI, L.P. (\"NBVP VI\"). North Bridge Venture Management VI, L.P. (\"NBVM VI\") is the sole general partner of NBVP VI and NBVM GP is the sole general partner of NBVM VI. Each of Anderson, a member of the Issuer's board of directors, and D'Amore are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP VI. Each of NBVM VI, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":69364},"source":{"system":"sec-edgar","filing":"0000899243-20-012179","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":30,"url":"https://www.sec.gov/Archives/edgar/data/1138402/000089924320012179/doc4.xml","form_type":"4"}},{"id":3159779,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":112846,"kind":"organization","name":"NBVM GP, LLC","position":1,"cik":"0001401650","reported_name":"NBVM GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46699,"kind":"person","name":"DAMORE RICHARD A","position":2,"cik":"0001206641","reported_name":"DAMORE RICHARD A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112847,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V A LP","position":3,"cik":"0001138402","reported_name":"NORTH BRIDGE VENTURE PARTNERS V A LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112848,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","position":4,"cik":"0001138399","reported_name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112849,"kind":"organization","name":"North Bridge Venture Partners VI L P","position":5,"cik":"0001327539","reported_name":"North Bridge Venture Partners VI L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112850,"kind":"organization","name":"North Bridge Venture Management V, L.P.","position":6,"cik":"0001297397","reported_name":"North Bridge Venture Management V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112851,"kind":"organization","name":"North Bridge Venture Management VI, L.P.","position":7,"cik":"0001590898","reported_name":"North Bridge Venture Management VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-4 Convertible Preferred Stock","published_at":"2020-05-06T19:38:21.000Z","date":"2020-05-05","kind":"exercise","acquired":false,"shares":1835743,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reportable securities are owned directly by North Bridge Venture Partners V-B, L.P. (\"NBVP V-B\"). NBVM V is the sole general partner of NBVP V-B and NBVM GP is the sole general partner of NBVM V. Each of Anderson, a member of the Issuer's board of directors, and D'Amore are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP V-B. Each of NBVM V, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":53236},"source":{"system":"sec-edgar","filing":"0000899243-20-012179","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":29,"url":"https://www.sec.gov/Archives/edgar/data/1138402/000089924320012179/doc4.xml","form_type":"4"}},{"id":3159778,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":112846,"kind":"organization","name":"NBVM GP, LLC","position":1,"cik":"0001401650","reported_name":"NBVM GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46699,"kind":"person","name":"DAMORE RICHARD A","position":2,"cik":"0001206641","reported_name":"DAMORE RICHARD A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112847,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V A LP","position":3,"cik":"0001138402","reported_name":"NORTH BRIDGE VENTURE PARTNERS V A LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112848,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","position":4,"cik":"0001138399","reported_name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112849,"kind":"organization","name":"North Bridge Venture Partners VI L P","position":5,"cik":"0001327539","reported_name":"North Bridge Venture Partners VI L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112850,"kind":"organization","name":"North Bridge Venture Management V, L.P.","position":6,"cik":"0001297397","reported_name":"North Bridge Venture Management V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112851,"kind":"organization","name":"North Bridge Venture Management VI, L.P.","position":7,"cik":"0001590898","reported_name":"North Bridge Venture Management VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-4 Convertible Preferred Stock","published_at":"2020-05-06T19:38:21.000Z","date":"2020-05-05","kind":"exercise","acquired":false,"shares":3745346,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reportable securities are owned directly by North Bridge Venture Partners V-A, L.P. (\"NBVP V-A\"). North Bridge Venture Management V, L.P. (\"NBVM V\") is the sole general partner of NBVP V-A and North Bridge Venture Management GP, LLC (\"NBVM GP\") is the sole general partner of NBVM V. Each of Edward T. Anderson (\"Anderson\"), a member of the Issuer's board of directors, and Richard A. D'Amore (\"D'Amore\") are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP V-A. Each of NBVM V, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":108614},"source":{"system":"sec-edgar","filing":"0000899243-20-012179","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":28,"url":"https://www.sec.gov/Archives/edgar/data/1138402/000089924320012179/doc4.xml","form_type":"4"}},{"id":3159777,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":112846,"kind":"organization","name":"NBVM GP, LLC","position":1,"cik":"0001401650","reported_name":"NBVM GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46699,"kind":"person","name":"DAMORE RICHARD A","position":2,"cik":"0001206641","reported_name":"DAMORE RICHARD A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112847,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V A LP","position":3,"cik":"0001138402","reported_name":"NORTH BRIDGE VENTURE PARTNERS V A LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112848,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","position":4,"cik":"0001138399","reported_name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112849,"kind":"organization","name":"North Bridge Venture Partners VI L P","position":5,"cik":"0001327539","reported_name":"North Bridge Venture Partners VI L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112850,"kind":"organization","name":"North Bridge Venture Management V, L.P.","position":6,"cik":"0001297397","reported_name":"North Bridge Venture Management V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112851,"kind":"organization","name":"North Bridge Venture Management VI, L.P.","position":7,"cik":"0001590898","reported_name":"North Bridge Venture Management VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-3 Convertible Preferred Stock","published_at":"2020-05-06T19:38:21.000Z","date":"2020-05-05","kind":"exercise","acquired":false,"shares":2929790,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reportable securities are owned directly by North Bridge Venture Partners VI, L.P. (\"NBVP VI\"). North Bridge Venture Management VI, L.P. (\"NBVM VI\") is the sole general partner of NBVP VI and NBVM GP is the sole general partner of NBVM VI. Each of Anderson, a member of the Issuer's board of directors, and D'Amore are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP VI. Each of NBVM VI, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":84963},"source":{"system":"sec-edgar","filing":"0000899243-20-012179","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":27,"url":"https://www.sec.gov/Archives/edgar/data/1138402/000089924320012179/doc4.xml","form_type":"4"}},{"id":3159776,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":112846,"kind":"organization","name":"NBVM GP, LLC","position":1,"cik":"0001401650","reported_name":"NBVM GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46699,"kind":"person","name":"DAMORE RICHARD A","position":2,"cik":"0001206641","reported_name":"DAMORE RICHARD A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112847,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V A LP","position":3,"cik":"0001138402","reported_name":"NORTH BRIDGE VENTURE PARTNERS V A LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112848,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","position":4,"cik":"0001138399","reported_name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112849,"kind":"organization","name":"North Bridge Venture Partners VI L P","position":5,"cik":"0001327539","reported_name":"North Bridge Venture Partners VI L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112850,"kind":"organization","name":"North Bridge Venture Management V, L.P.","position":6,"cik":"0001297397","reported_name":"North Bridge Venture Management V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112851,"kind":"organization","name":"North Bridge Venture Management VI, L.P.","position":7,"cik":"0001590898","reported_name":"North Bridge Venture Management VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-3 Convertible Preferred Stock","published_at":"2020-05-06T19:38:21.000Z","date":"2020-05-05","kind":"exercise","acquired":false,"shares":2248569,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reportable securities are owned directly by North Bridge Venture Partners V-B, L.P. (\"NBVP V-B\"). NBVM V is the sole general partner of NBVP V-B and NBVM GP is the sole general partner of NBVM V. Each of Anderson, a member of the Issuer's board of directors, and D'Amore are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP V-B. Each of NBVM V, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":65208},"source":{"system":"sec-edgar","filing":"0000899243-20-012179","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":26,"url":"https://www.sec.gov/Archives/edgar/data/1138402/000089924320012179/doc4.xml","form_type":"4"}},{"id":3159775,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":112846,"kind":"organization","name":"NBVM GP, LLC","position":1,"cik":"0001401650","reported_name":"NBVM GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46699,"kind":"person","name":"DAMORE RICHARD A","position":2,"cik":"0001206641","reported_name":"DAMORE RICHARD A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112847,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V A LP","position":3,"cik":"0001138402","reported_name":"NORTH BRIDGE VENTURE PARTNERS V A LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112848,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","position":4,"cik":"0001138399","reported_name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112849,"kind":"organization","name":"North Bridge Venture Partners VI L P","position":5,"cik":"0001327539","reported_name":"North Bridge Venture Partners VI L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112850,"kind":"organization","name":"North Bridge Venture Management V, L.P.","position":6,"cik":"0001297397","reported_name":"North Bridge Venture Management V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112851,"kind":"organization","name":"North Bridge Venture Management VI, L.P.","position":7,"cik":"0001590898","reported_name":"North Bridge Venture Management VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-3 Convertible Preferred Stock","published_at":"2020-05-06T19:38:21.000Z","date":"2020-05-05","kind":"exercise","acquired":false,"shares":4587608,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reportable securities are owned directly by North Bridge Venture Partners V-A, L.P. (\"NBVP V-A\"). North Bridge Venture Management V, L.P. (\"NBVM V\") is the sole general partner of NBVP V-A and North Bridge Venture Management GP, LLC (\"NBVM GP\") is the sole general partner of NBVM V. Each of Edward T. Anderson (\"Anderson\"), a member of the Issuer's board of directors, and Richard A. D'Amore (\"D'Amore\") are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP V-A. Each of NBVM V, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":133039},"source":{"system":"sec-edgar","filing":"0000899243-20-012179","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":25,"url":"https://www.sec.gov/Archives/edgar/data/1138402/000089924320012179/doc4.xml","form_type":"4"}},{"id":3159774,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":112846,"kind":"organization","name":"NBVM GP, LLC","position":1,"cik":"0001401650","reported_name":"NBVM GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46699,"kind":"person","name":"DAMORE RICHARD A","position":2,"cik":"0001206641","reported_name":"DAMORE RICHARD A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112847,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V A LP","position":3,"cik":"0001138402","reported_name":"NORTH BRIDGE VENTURE PARTNERS V A LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112848,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","position":4,"cik":"0001138399","reported_name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112849,"kind":"organization","name":"North Bridge Venture Partners VI L P","position":5,"cik":"0001327539","reported_name":"North Bridge Venture Partners VI L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112850,"kind":"organization","name":"North Bridge Venture Management V, L.P.","position":6,"cik":"0001297397","reported_name":"North Bridge Venture Management V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112851,"kind":"organization","name":"North Bridge Venture Management VI, L.P.","position":7,"cik":"0001590898","reported_name":"North Bridge Venture Management VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-2 Convertible Preferred Stock","published_at":"2020-05-06T19:38:21.000Z","date":"2020-05-05","kind":"exercise","acquired":false,"shares":2088772,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reportable securities are owned directly by North Bridge Venture Partners VI, L.P. (\"NBVP VI\"). North Bridge Venture Management VI, L.P. (\"NBVM VI\") is the sole general partner of NBVP VI and NBVM GP is the sole general partner of NBVM VI. Each of Anderson, a member of the Issuer's board of directors, and D'Amore are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP VI. Each of NBVM VI, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":60573},"source":{"system":"sec-edgar","filing":"0000899243-20-012179","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/1138402/000089924320012179/doc4.xml","form_type":"4"}},{"id":3159773,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":112846,"kind":"organization","name":"NBVM GP, LLC","position":1,"cik":"0001401650","reported_name":"NBVM GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46699,"kind":"person","name":"DAMORE RICHARD A","position":2,"cik":"0001206641","reported_name":"DAMORE RICHARD A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112847,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V A LP","position":3,"cik":"0001138402","reported_name":"NORTH BRIDGE VENTURE PARTNERS V A LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112848,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","position":4,"cik":"0001138399","reported_name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112849,"kind":"organization","name":"North Bridge Venture Partners VI L P","position":5,"cik":"0001327539","reported_name":"North Bridge Venture Partners VI L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112850,"kind":"organization","name":"North Bridge Venture Management V, L.P.","position":6,"cik":"0001297397","reported_name":"North Bridge Venture Management V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112851,"kind":"organization","name":"North Bridge Venture Management VI, L.P.","position":7,"cik":"0001590898","reported_name":"North Bridge Venture Management VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-2 Convertible Preferred Stock","published_at":"2020-05-06T19:38:21.000Z","date":"2020-05-05","kind":"exercise","acquired":false,"shares":1603102,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reportable securities are owned directly by North Bridge Venture Partners V-B, L.P. (\"NBVP V-B\"). NBVM V is the sole general partner of NBVP V-B and NBVM GP is the sole general partner of NBVM V. Each of Anderson, a member of the Issuer's board of directors, and D'Amore are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP V-B. Each of NBVM V, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":46489},"source":{"system":"sec-edgar","filing":"0000899243-20-012179","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/1138402/000089924320012179/doc4.xml","form_type":"4"}},{"id":3159772,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":112846,"kind":"organization","name":"NBVM GP, LLC","position":1,"cik":"0001401650","reported_name":"NBVM GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46699,"kind":"person","name":"DAMORE RICHARD A","position":2,"cik":"0001206641","reported_name":"DAMORE RICHARD A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112847,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V A LP","position":3,"cik":"0001138402","reported_name":"NORTH BRIDGE VENTURE PARTNERS V A LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112848,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","position":4,"cik":"0001138399","reported_name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112849,"kind":"organization","name":"North Bridge Venture Partners VI L P","position":5,"cik":"0001327539","reported_name":"North Bridge Venture Partners VI L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112850,"kind":"organization","name":"North Bridge Venture Management V, L.P.","position":6,"cik":"0001297397","reported_name":"North Bridge Venture Management V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112851,"kind":"organization","name":"North Bridge Venture Management VI, L.P.","position":7,"cik":"0001590898","reported_name":"North Bridge Venture Management VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-2 Convertible Preferred Stock","published_at":"2020-05-06T19:38:21.000Z","date":"2020-05-05","kind":"exercise","acquired":false,"shares":3270702,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reportable securities are owned directly by North Bridge Venture Partners V-A, L.P. (\"NBVP V-A\"). North Bridge Venture Management V, L.P. (\"NBVM V\") is the sole general partner of NBVP V-A and North Bridge Venture Management GP, LLC (\"NBVM GP\") is the sole general partner of NBVM V. Each of Edward T. Anderson (\"Anderson\"), a member of the Issuer's board of directors, and Richard A. D'Amore (\"D'Amore\") are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP V-A. Each of NBVM V, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":94849},"source":{"system":"sec-edgar","filing":"0000899243-20-012179","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1138402/000089924320012179/doc4.xml","form_type":"4"}},{"id":3159771,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":112846,"kind":"organization","name":"NBVM GP, LLC","position":1,"cik":"0001401650","reported_name":"NBVM GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46699,"kind":"person","name":"DAMORE RICHARD A","position":2,"cik":"0001206641","reported_name":"DAMORE RICHARD A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112847,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V A LP","position":3,"cik":"0001138402","reported_name":"NORTH BRIDGE VENTURE PARTNERS V A LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112848,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","position":4,"cik":"0001138399","reported_name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112849,"kind":"organization","name":"North Bridge Venture Partners VI L P","position":5,"cik":"0001327539","reported_name":"North Bridge Venture Partners VI L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112850,"kind":"organization","name":"North Bridge Venture Management V, L.P.","position":6,"cik":"0001297397","reported_name":"North Bridge Venture Management V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112851,"kind":"organization","name":"North Bridge Venture Management VI, L.P.","position":7,"cik":"0001590898","reported_name":"North Bridge Venture Management VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-1/C Convertible Preferred Stock","published_at":"2020-05-06T19:38:21.000Z","date":"2020-05-05","kind":"exercise","acquired":false,"shares":1948948,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reportable securities are owned directly by North Bridge Venture Partners VI, L.P. (\"NBVP VI\"). North Bridge Venture Management VI, L.P. (\"NBVM VI\") is the sole general partner of NBVP VI and NBVM GP is the sole general partner of NBVM VI. Each of Anderson, a member of the Issuer's board of directors, and D'Amore are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP VI. Each of NBVM VI, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":56519},"source":{"system":"sec-edgar","filing":"0000899243-20-012179","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1138402/000089924320012179/doc4.xml","form_type":"4"}},{"id":3159770,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":112846,"kind":"organization","name":"NBVM GP, LLC","position":1,"cik":"0001401650","reported_name":"NBVM GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46699,"kind":"person","name":"DAMORE RICHARD A","position":2,"cik":"0001206641","reported_name":"DAMORE RICHARD A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112847,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V A LP","position":3,"cik":"0001138402","reported_name":"NORTH BRIDGE VENTURE PARTNERS V A LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112848,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","position":4,"cik":"0001138399","reported_name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112849,"kind":"organization","name":"North Bridge Venture Partners VI L P","position":5,"cik":"0001327539","reported_name":"North Bridge Venture Partners VI L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112850,"kind":"organization","name":"North Bridge Venture Management V, L.P.","position":6,"cik":"0001297397","reported_name":"North Bridge Venture Management V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112851,"kind":"organization","name":"North Bridge Venture Management VI, L.P.","position":7,"cik":"0001590898","reported_name":"North Bridge Venture Management VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-1/C Convertible Preferred Stock","published_at":"2020-05-06T19:38:21.000Z","date":"2020-05-05","kind":"exercise","acquired":false,"shares":1495786,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reportable securities are owned directly by North Bridge Venture Partners V-B, L.P. (\"NBVP V-B\"). NBVM V is the sole general partner of NBVP V-B and NBVM GP is the sole general partner of NBVM V. Each of Anderson, a member of the Issuer's board of directors, and D'Amore are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP V-B. Each of NBVM V, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":43377},"source":{"system":"sec-edgar","filing":"0000899243-20-012179","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1138402/000089924320012179/doc4.xml","form_type":"4"}},{"id":3159769,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":112846,"kind":"organization","name":"NBVM GP, LLC","position":1,"cik":"0001401650","reported_name":"NBVM GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46699,"kind":"person","name":"DAMORE RICHARD A","position":2,"cik":"0001206641","reported_name":"DAMORE RICHARD A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112847,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V A LP","position":3,"cik":"0001138402","reported_name":"NORTH BRIDGE VENTURE PARTNERS V A LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112848,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","position":4,"cik":"0001138399","reported_name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112849,"kind":"organization","name":"North Bridge Venture Partners VI L P","position":5,"cik":"0001327539","reported_name":"North Bridge Venture Partners VI L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112850,"kind":"organization","name":"North Bridge Venture Management V, L.P.","position":6,"cik":"0001297397","reported_name":"North Bridge Venture Management V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112851,"kind":"organization","name":"North Bridge Venture Management VI, L.P.","position":7,"cik":"0001590898","reported_name":"North Bridge Venture Management VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-1/C Convertible Preferred Stock","published_at":"2020-05-06T19:38:21.000Z","date":"2020-05-05","kind":"exercise","acquired":false,"shares":3051758,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reportable securities are owned directly by North Bridge Venture Partners V-A, L.P. (\"NBVP V-A\"). North Bridge Venture Management V, L.P. (\"NBVM V\") is the sole general partner of NBVP V-A and North Bridge Venture Management GP, LLC (\"NBVM GP\") is the sole general partner of NBVM V. Each of Edward T. Anderson (\"Anderson\"), a member of the Issuer's board of directors, and Richard A. D'Amore (\"D'Amore\") are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP V-A. Each of NBVM V, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":88500},"source":{"system":"sec-edgar","filing":"0000899243-20-012179","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1138402/000089924320012179/doc4.xml","form_type":"4"}},{"id":3159768,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":112846,"kind":"organization","name":"NBVM GP, LLC","position":1,"cik":"0001401650","reported_name":"NBVM GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46699,"kind":"person","name":"DAMORE RICHARD A","position":2,"cik":"0001206641","reported_name":"DAMORE RICHARD A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112847,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V A LP","position":3,"cik":"0001138402","reported_name":"NORTH BRIDGE VENTURE PARTNERS V A LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112848,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","position":4,"cik":"0001138399","reported_name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112849,"kind":"organization","name":"North Bridge Venture Partners VI L P","position":5,"cik":"0001327539","reported_name":"North Bridge Venture Partners VI L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112850,"kind":"organization","name":"North Bridge Venture Management V, L.P.","position":6,"cik":"0001297397","reported_name":"North Bridge Venture Management V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112851,"kind":"organization","name":"North Bridge Venture Management VI, L.P.","position":7,"cik":"0001590898","reported_name":"North Bridge Venture Management VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-1/B Convertible Preferred Stock","published_at":"2020-05-06T19:38:21.000Z","date":"2020-05-05","kind":"exercise","acquired":false,"shares":1647727,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reportable securities are owned directly by North Bridge Venture Partners VI, L.P. (\"NBVP VI\"). North Bridge Venture Management VI, L.P. (\"NBVM VI\") is the sole general partner of NBVP VI and NBVM GP is the sole general partner of NBVM VI. Each of Anderson, a member of the Issuer's board of directors, and D'Amore are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP VI. Each of NBVM VI, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":47783},"source":{"system":"sec-edgar","filing":"0000899243-20-012179","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1138402/000089924320012179/doc4.xml","form_type":"4"}},{"id":3159767,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":112846,"kind":"organization","name":"NBVM GP, LLC","position":1,"cik":"0001401650","reported_name":"NBVM GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46699,"kind":"person","name":"DAMORE RICHARD A","position":2,"cik":"0001206641","reported_name":"DAMORE RICHARD A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112847,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V A LP","position":3,"cik":"0001138402","reported_name":"NORTH BRIDGE VENTURE PARTNERS V A LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112848,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","position":4,"cik":"0001138399","reported_name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112849,"kind":"organization","name":"North Bridge Venture Partners VI L P","position":5,"cik":"0001327539","reported_name":"North Bridge Venture Partners VI L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112850,"kind":"organization","name":"North Bridge Venture Management V, L.P.","position":6,"cik":"0001297397","reported_name":"North Bridge Venture Management V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112851,"kind":"organization","name":"North Bridge Venture Management VI, L.P.","position":7,"cik":"0001590898","reported_name":"North Bridge Venture Management VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-1/B Convertible Preferred Stock","published_at":"2020-05-06T19:38:21.000Z","date":"2020-05-05","kind":"exercise","acquired":false,"shares":541973,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reportable securities are owned directly by North Bridge Venture Partners V-B, L.P. (\"NBVP V-B\"). NBVM V is the sole general partner of NBVP V-B and NBVM GP is the sole general partner of NBVM V. Each of Anderson, a member of the Issuer's board of directors, and D'Amore are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP V-B. Each of NBVM V, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":15717},"source":{"system":"sec-edgar","filing":"0000899243-20-012179","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1138402/000089924320012179/doc4.xml","form_type":"4"}},{"id":3159766,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":112846,"kind":"organization","name":"NBVM GP, LLC","position":1,"cik":"0001401650","reported_name":"NBVM GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46699,"kind":"person","name":"DAMORE RICHARD A","position":2,"cik":"0001206641","reported_name":"DAMORE RICHARD A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112847,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V A LP","position":3,"cik":"0001138402","reported_name":"NORTH BRIDGE VENTURE PARTNERS V A LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112848,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","position":4,"cik":"0001138399","reported_name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112849,"kind":"organization","name":"North Bridge Venture Partners VI L P","position":5,"cik":"0001327539","reported_name":"North Bridge Venture Partners VI L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112850,"kind":"organization","name":"North Bridge Venture Management V, L.P.","position":6,"cik":"0001297397","reported_name":"North Bridge Venture Management V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112851,"kind":"organization","name":"North Bridge Venture Management VI, L.P.","position":7,"cik":"0001590898","reported_name":"North Bridge Venture Management VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-1/B Convertible Preferred Stock","published_at":"2020-05-06T19:38:21.000Z","date":"2020-05-05","kind":"exercise","acquired":false,"shares":1105754,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reportable securities are owned directly by North Bridge Venture Partners V-A, L.P. (\"NBVP V-A\"). North Bridge Venture Management V, L.P. (\"NBVM V\") is the sole general partner of NBVP V-A and North Bridge Venture Management GP, LLC (\"NBVM GP\") is the sole general partner of NBVM V. Each of Edward T. Anderson (\"Anderson\"), a member of the Issuer's board of directors, and Richard A. D'Amore (\"D'Amore\") are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP V-A. Each of NBVM V, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":32066},"source":{"system":"sec-edgar","filing":"0000899243-20-012179","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1138402/000089924320012179/doc4.xml","form_type":"4"}},{"id":3159765,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":112846,"kind":"organization","name":"NBVM GP, LLC","position":1,"cik":"0001401650","reported_name":"NBVM GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46699,"kind":"person","name":"DAMORE RICHARD A","position":2,"cik":"0001206641","reported_name":"DAMORE RICHARD A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112847,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V A LP","position":3,"cik":"0001138402","reported_name":"NORTH BRIDGE VENTURE PARTNERS V A LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112848,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","position":4,"cik":"0001138399","reported_name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112849,"kind":"organization","name":"North Bridge Venture Partners VI L P","position":5,"cik":"0001327539","reported_name":"North Bridge Venture Partners VI L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112850,"kind":"organization","name":"North Bridge Venture Management V, L.P.","position":6,"cik":"0001297397","reported_name":"North Bridge Venture Management V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112851,"kind":"organization","name":"North Bridge Venture Management VI, L.P.","position":7,"cik":"0001590898","reported_name":"North Bridge Venture Management VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-1/A Convertible Preferred Stock","published_at":"2020-05-06T19:38:21.000Z","date":"2020-05-05","kind":"exercise","acquired":false,"shares":1725090,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reportable securities are owned directly by North Bridge Venture Partners VI, L.P. (\"NBVP VI\"). North Bridge Venture Management VI, L.P. (\"NBVM VI\") is the sole general partner of NBVP VI and NBVM GP is the sole general partner of NBVM VI. Each of Anderson, a member of the Issuer's board of directors, and D'Amore are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP VI. Each of NBVM VI, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":50027},"source":{"system":"sec-edgar","filing":"0000899243-20-012179","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1138402/000089924320012179/doc4.xml","form_type":"4"}},{"id":3159764,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":112846,"kind":"organization","name":"NBVM GP, LLC","position":1,"cik":"0001401650","reported_name":"NBVM GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46699,"kind":"person","name":"DAMORE RICHARD A","position":2,"cik":"0001206641","reported_name":"DAMORE RICHARD A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112847,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V A LP","position":3,"cik":"0001138402","reported_name":"NORTH BRIDGE VENTURE PARTNERS V A LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112848,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","position":4,"cik":"0001138399","reported_name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112849,"kind":"organization","name":"North Bridge Venture Partners VI L P","position":5,"cik":"0001327539","reported_name":"North Bridge Venture Partners VI L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112850,"kind":"organization","name":"North Bridge Venture Management V, L.P.","position":6,"cik":"0001297397","reported_name":"North Bridge Venture Management V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112851,"kind":"organization","name":"North Bridge Venture Management VI, L.P.","position":7,"cik":"0001590898","reported_name":"North Bridge Venture Management VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-1/A Convertible Preferred Stock","published_at":"2020-05-06T19:38:21.000Z","date":"2020-05-05","kind":"exercise","acquired":false,"shares":567420,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reportable securities are owned directly by North Bridge Venture Partners V-B, L.P. (\"NBVP V-B\"). NBVM V is the sole general partner of NBVP V-B and NBVM GP is the sole general partner of NBVM V. Each of Anderson, a member of the Issuer's board of directors, and D'Amore are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP V-B. Each of NBVM V, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":16455},"source":{"system":"sec-edgar","filing":"0000899243-20-012179","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1138402/000089924320012179/doc4.xml","form_type":"4"}},{"id":3159763,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":112846,"kind":"organization","name":"NBVM GP, LLC","position":1,"cik":"0001401650","reported_name":"NBVM GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46699,"kind":"person","name":"DAMORE RICHARD A","position":2,"cik":"0001206641","reported_name":"DAMORE RICHARD A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112847,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V A LP","position":3,"cik":"0001138402","reported_name":"NORTH BRIDGE VENTURE PARTNERS V A LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112848,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","position":4,"cik":"0001138399","reported_name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112849,"kind":"organization","name":"North Bridge Venture Partners VI L P","position":5,"cik":"0001327539","reported_name":"North Bridge Venture Partners VI L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112850,"kind":"organization","name":"North Bridge Venture Management V, L.P.","position":6,"cik":"0001297397","reported_name":"North Bridge Venture Management V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112851,"kind":"organization","name":"North Bridge Venture Management VI, L.P.","position":7,"cik":"0001590898","reported_name":"North Bridge Venture Management VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-1/A Convertible Preferred Stock","published_at":"2020-05-06T19:38:21.000Z","date":"2020-05-05","kind":"exercise","acquired":false,"shares":1157670,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reportable securities are owned directly by North Bridge Venture Partners V-A, L.P. (\"NBVP V-A\"). North Bridge Venture Management V, L.P. (\"NBVM V\") is the sole general partner of NBVP V-A and North Bridge Venture Management GP, LLC (\"NBVM GP\") is the sole general partner of NBVM V. Each of Edward T. Anderson (\"Anderson\"), a member of the Issuer's board of directors, and Richard A. D'Amore (\"D'Amore\") are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP V-A. Each of NBVM V, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":33572},"source":{"system":"sec-edgar","filing":"0000899243-20-012179","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1138402/000089924320012179/doc4.xml","form_type":"4"}},{"id":3159762,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":112846,"kind":"organization","name":"NBVM GP, LLC","position":1,"cik":"0001401650","reported_name":"NBVM GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46699,"kind":"person","name":"DAMORE RICHARD A","position":2,"cik":"0001206641","reported_name":"DAMORE RICHARD A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112847,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V A LP","position":3,"cik":"0001138402","reported_name":"NORTH BRIDGE VENTURE PARTNERS V A LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112848,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","position":4,"cik":"0001138399","reported_name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112849,"kind":"organization","name":"North Bridge Venture Partners VI L P","position":5,"cik":"0001327539","reported_name":"North Bridge Venture Partners VI L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112850,"kind":"organization","name":"North Bridge Venture Management V, L.P.","position":6,"cik":"0001297397","reported_name":"North Bridge Venture Management V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112851,"kind":"organization","name":"North Bridge Venture Management VI, L.P.","position":7,"cik":"0001590898","reported_name":"North Bridge Venture Management VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-05-06T19:38:21.000Z","date":"2020-05-05","kind":"purchase","acquired":true,"shares":75000,"price":16,"value":1200000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reportable securities are owned directly by North Bridge Venture Partners VI, L.P. (\"NBVP VI\"). North Bridge Venture Management VI, L.P. (\"NBVM VI\") is the sole general partner of NBVP VI and NBVM GP is the sole general partner of NBVM VI. Each of Anderson, a member of the Issuer's board of directors, and D'Amore are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP VI. Each of NBVM VI, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":553123,"source":{"system":"sec-edgar","filing":"0000899243-20-012179","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1138402/000089924320012179/doc4.xml","form_type":"4"}},{"id":3159761,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":112846,"kind":"organization","name":"NBVM GP, LLC","position":1,"cik":"0001401650","reported_name":"NBVM GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46699,"kind":"person","name":"DAMORE RICHARD A","position":2,"cik":"0001206641","reported_name":"DAMORE RICHARD A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112847,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V A LP","position":3,"cik":"0001138402","reported_name":"NORTH BRIDGE VENTURE PARTNERS V A LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112848,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","position":4,"cik":"0001138399","reported_name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112849,"kind":"organization","name":"North Bridge Venture Partners VI L P","position":5,"cik":"0001327539","reported_name":"North Bridge Venture Partners VI L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112850,"kind":"organization","name":"North Bridge Venture Management V, L.P.","position":6,"cik":"0001297397","reported_name":"North Bridge Venture Management V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112851,"kind":"organization","name":"North Bridge Venture Management VI, L.P.","position":7,"cik":"0001590898","reported_name":"North Bridge Venture Management VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-05-06T19:38:21.000Z","date":"2020-05-05","kind":"purchase","acquired":true,"shares":57561,"price":16,"value":920976.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reportable securities are owned directly by North Bridge Venture Partners V-B, L.P. (\"NBVP V-B\"). NBVM V is the sole general partner of NBVP V-B and NBVM GP is the sole general partner of NBVM V. Each of Anderson, a member of the Issuer's board of directors, and D'Amore are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP V-B. Each of NBVM V, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":381618,"source":{"system":"sec-edgar","filing":"0000899243-20-012179","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1138402/000089924320012179/doc4.xml","form_type":"4"}},{"id":3159760,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":112846,"kind":"organization","name":"NBVM GP, LLC","position":1,"cik":"0001401650","reported_name":"NBVM GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46699,"kind":"person","name":"DAMORE RICHARD A","position":2,"cik":"0001206641","reported_name":"DAMORE RICHARD A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112847,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V A LP","position":3,"cik":"0001138402","reported_name":"NORTH BRIDGE VENTURE PARTNERS V A LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112848,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","position":4,"cik":"0001138399","reported_name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112849,"kind":"organization","name":"North Bridge Venture Partners VI L P","position":5,"cik":"0001327539","reported_name":"North Bridge Venture Partners VI L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112850,"kind":"organization","name":"North Bridge Venture Management V, L.P.","position":6,"cik":"0001297397","reported_name":"North Bridge Venture Management V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112851,"kind":"organization","name":"North Bridge Venture Management VI, L.P.","position":7,"cik":"0001590898","reported_name":"North Bridge Venture Management VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-05-06T19:38:21.000Z","date":"2020-05-05","kind":"purchase","acquired":true,"shares":117439,"price":16,"value":1879024.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reportable securities are owned directly by North Bridge Venture Partners V-A, L.P. (\"NBVP V-A\"). North Bridge Venture Management V, L.P. (\"NBVM V\") is the sole general partner of NBVP V-A and North Bridge Venture Management GP, LLC (\"NBVM GP\") is the sole general partner of NBVM V. Each of Edward T. Anderson (\"Anderson\"), a member of the Issuer's board of directors, and Richard A. D'Amore (\"D'Amore\") are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP V-A. Each of NBVM V, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":778592,"source":{"system":"sec-edgar","filing":"0000899243-20-012179","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1138402/000089924320012179/doc4.xml","form_type":"4"}},{"id":3159759,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":112846,"kind":"organization","name":"NBVM GP, LLC","position":1,"cik":"0001401650","reported_name":"NBVM GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46699,"kind":"person","name":"DAMORE RICHARD A","position":2,"cik":"0001206641","reported_name":"DAMORE RICHARD A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112847,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V A LP","position":3,"cik":"0001138402","reported_name":"NORTH BRIDGE VENTURE PARTNERS V A LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112848,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","position":4,"cik":"0001138399","reported_name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112849,"kind":"organization","name":"North Bridge Venture Partners VI L P","position":5,"cik":"0001327539","reported_name":"North Bridge Venture Partners VI L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112850,"kind":"organization","name":"North Bridge Venture Management V, L.P.","position":6,"cik":"0001297397","reported_name":"North Bridge Venture Management V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112851,"kind":"organization","name":"North Bridge Venture Management VI, L.P.","position":7,"cik":"0001590898","reported_name":"North Bridge Venture Management VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-05-06T19:38:21.000Z","date":"2020-05-05","kind":"sale","acquired":false,"shares":7255,"price":16,"value":116080.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"On May 5, 2020, NBVP VI exercised a warrant to purchase 13,449 shares of the Issuer's common stock for $16.00 a share, which represents the Issuer's initial public offering price. In connection with the automatic net exercise of the warrant immediately prior to the closing of the Issuer's initial public offering, the Issuer withheld 7,255 of the warrant shares to pay the exercise price and issued the remaining warrant shares to NBVP VI. The Issuer also paid $15.13 to NBVP VI in lieu of a fractional share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reportable securities are owned directly by North Bridge Venture Partners VI, L.P. (\"NBVP VI\"). North Bridge Venture Management VI, L.P. (\"NBVM VI\") is the sole general partner of NBVP VI and NBVM GP is the sole general partner of NBVM VI. Each of Anderson, a member of the Issuer's board of directors, and D'Amore are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP VI. Each of NBVM VI, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":478123,"source":{"system":"sec-edgar","filing":"0000899243-20-012179","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1138402/000089924320012179/doc4.xml","form_type":"4"}},{"id":3159758,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":112846,"kind":"organization","name":"NBVM GP, LLC","position":1,"cik":"0001401650","reported_name":"NBVM GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46699,"kind":"person","name":"DAMORE RICHARD A","position":2,"cik":"0001206641","reported_name":"DAMORE RICHARD A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112847,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V A LP","position":3,"cik":"0001138402","reported_name":"NORTH BRIDGE VENTURE PARTNERS V A LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112848,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","position":4,"cik":"0001138399","reported_name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112849,"kind":"organization","name":"North Bridge Venture Partners VI L P","position":5,"cik":"0001327539","reported_name":"North Bridge Venture Partners VI L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112850,"kind":"organization","name":"North Bridge Venture Management V, L.P.","position":6,"cik":"0001297397","reported_name":"North Bridge Venture Management V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112851,"kind":"organization","name":"North Bridge Venture Management VI, L.P.","position":7,"cik":"0001590898","reported_name":"North Bridge Venture Management VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-05-06T19:38:21.000Z","date":"2020-05-05","kind":"other","acquired":true,"shares":13449,"price":8.63,"value":116064.87,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reportable securities are owned directly by North Bridge Venture Partners VI, L.P. (\"NBVP VI\"). North Bridge Venture Management VI, L.P. (\"NBVM VI\") is the sole general partner of NBVP VI and NBVM GP is the sole general partner of NBVM VI. Each of Anderson, a member of the Issuer's board of directors, and D'Amore are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP VI. Each of NBVM VI, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":485378,"source":{"system":"sec-edgar","filing":"0000899243-20-012179","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1138402/000089924320012179/doc4.xml","form_type":"4"}},{"id":3159757,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":112846,"kind":"organization","name":"NBVM GP, LLC","position":1,"cik":"0001401650","reported_name":"NBVM GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46699,"kind":"person","name":"DAMORE RICHARD A","position":2,"cik":"0001206641","reported_name":"DAMORE RICHARD A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112847,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V A LP","position":3,"cik":"0001138402","reported_name":"NORTH BRIDGE VENTURE PARTNERS V A LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112848,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","position":4,"cik":"0001138399","reported_name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112849,"kind":"organization","name":"North Bridge Venture Partners VI L P","position":5,"cik":"0001327539","reported_name":"North Bridge Venture Partners VI L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112850,"kind":"organization","name":"North Bridge Venture Management V, L.P.","position":6,"cik":"0001297397","reported_name":"North Bridge Venture Management V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112851,"kind":"organization","name":"North Bridge Venture Management VI, L.P.","position":7,"cik":"0001590898","reported_name":"North Bridge Venture Management VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-05-06T19:38:21.000Z","date":"2020-05-05","kind":"sale","acquired":false,"shares":5568,"price":16,"value":89088.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"On May 5, 2020, NBVP V-B exercised a warrant to purchsae 10,322 shares of the Issuer's common stock for $16.00 a share, which represents the Issuer's initial public offering price. In connection with the automatic net exercise of the warrant immediately prior to the closing of the Issuer's initial public offering, the Issuer withheld 5,568 of the warrant shares to pay the exercise price and issued the remaining warrant shares to NBVP V-B. The Issuer also paid $9.14 to NBVP V-B in lieu of a fractional share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reportable securities are owned directly by North Bridge Venture Partners V-B, L.P. (\"NBVP V-B\"). NBVM V is the sole general partner of NBVP V-B and NBVM GP is the sole general partner of NBVM V. Each of Anderson, a member of the Issuer's board of directors, and D'Amore are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP V-B. Each of NBVM V, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":324057,"source":{"system":"sec-edgar","filing":"0000899243-20-012179","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1138402/000089924320012179/doc4.xml","form_type":"4"}},{"id":3159756,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":112846,"kind":"organization","name":"NBVM GP, LLC","position":1,"cik":"0001401650","reported_name":"NBVM GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46699,"kind":"person","name":"DAMORE RICHARD A","position":2,"cik":"0001206641","reported_name":"DAMORE RICHARD A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112847,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V A LP","position":3,"cik":"0001138402","reported_name":"NORTH BRIDGE VENTURE PARTNERS V A LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112848,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","position":4,"cik":"0001138399","reported_name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112849,"kind":"organization","name":"North Bridge Venture Partners VI L P","position":5,"cik":"0001327539","reported_name":"North Bridge Venture Partners VI L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112850,"kind":"organization","name":"North Bridge Venture Management V, L.P.","position":6,"cik":"0001297397","reported_name":"North Bridge Venture Management V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112851,"kind":"organization","name":"North Bridge Venture Management VI, L.P.","position":7,"cik":"0001590898","reported_name":"North Bridge Venture Management VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-05-06T19:38:21.000Z","date":"2020-05-05","kind":"other","acquired":true,"shares":10322,"price":8.63,"value":89078.86,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reportable securities are owned directly by North Bridge Venture Partners V-B, L.P. (\"NBVP V-B\"). NBVM V is the sole general partner of NBVP V-B and NBVM GP is the sole general partner of NBVM V. Each of Anderson, a member of the Issuer's board of directors, and D'Amore are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP V-B. Each of NBVM V, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":329625,"source":{"system":"sec-edgar","filing":"0000899243-20-012179","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1138402/000089924320012179/doc4.xml","form_type":"4"}},{"id":3159755,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":112846,"kind":"organization","name":"NBVM GP, LLC","position":1,"cik":"0001401650","reported_name":"NBVM GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46699,"kind":"person","name":"DAMORE RICHARD A","position":2,"cik":"0001206641","reported_name":"DAMORE RICHARD A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112847,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V A LP","position":3,"cik":"0001138402","reported_name":"NORTH BRIDGE VENTURE PARTNERS V A LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112848,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","position":4,"cik":"0001138399","reported_name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112849,"kind":"organization","name":"North Bridge Venture Partners VI L P","position":5,"cik":"0001327539","reported_name":"North Bridge Venture Partners VI L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112850,"kind":"organization","name":"North Bridge Venture Management V, L.P.","position":6,"cik":"0001297397","reported_name":"North Bridge Venture Management V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112851,"kind":"organization","name":"North Bridge Venture Management VI, L.P.","position":7,"cik":"0001590898","reported_name":"North Bridge Venture Management VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-05-06T19:38:21.000Z","date":"2020-05-05","kind":"sale","acquired":false,"shares":11360,"price":16,"value":181760.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"On May 5, 2020, NBVP V-A exercised a warrant to purchase 21,060 shares of the Issuer's common stock for $16.00 a share, which represents the Issuer's initial public offering price. In connection with the automatic net exercise of the warrant immediately prior to the closing of the Issuer's initial public offering, the Issuer withheld 11,360 of the warrant shares to pay the exercise price and issued the remaining warrant shares to NBVP V-A. The Issuer also paid $12.20 to NBVP V-A in lieu of a fractional share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reportable securities are owned directly by North Bridge Venture Partners V-A, L.P. (\"NBVP V-A\"). North Bridge Venture Management V, L.P. (\"NBVM V\") is the sole general partner of NBVP V-A and North Bridge Venture Management GP, LLC (\"NBVM GP\") is the sole general partner of NBVM V. Each of Edward T. Anderson (\"Anderson\"), a member of the Issuer's board of directors, and Richard A. D'Amore (\"D'Amore\") are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP V-A. Each of NBVM V, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":661153,"source":{"system":"sec-edgar","filing":"0000899243-20-012179","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1138402/000089924320012179/doc4.xml","form_type":"4"}},{"id":3159754,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":112846,"kind":"organization","name":"NBVM GP, LLC","position":1,"cik":"0001401650","reported_name":"NBVM GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46699,"kind":"person","name":"DAMORE RICHARD A","position":2,"cik":"0001206641","reported_name":"DAMORE RICHARD A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112847,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V A LP","position":3,"cik":"0001138402","reported_name":"NORTH BRIDGE VENTURE PARTNERS V A LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112848,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","position":4,"cik":"0001138399","reported_name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112849,"kind":"organization","name":"North Bridge Venture Partners VI L P","position":5,"cik":"0001327539","reported_name":"North Bridge Venture Partners VI L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112850,"kind":"organization","name":"North Bridge Venture Management V, L.P.","position":6,"cik":"0001297397","reported_name":"North Bridge Venture Management V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112851,"kind":"organization","name":"North Bridge Venture Management VI, L.P.","position":7,"cik":"0001590898","reported_name":"North Bridge Venture Management VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-05-06T19:38:21.000Z","date":"2020-05-05","kind":"other","acquired":true,"shares":21060,"price":8.63,"value":181747.8,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reportable securities are owned directly by North Bridge Venture Partners V-A, L.P. (\"NBVP V-A\"). North Bridge Venture Management V, L.P. (\"NBVM V\") is the sole general partner of NBVP V-A and North Bridge Venture Management GP, LLC (\"NBVM GP\") is the sole general partner of NBVM V. Each of Edward T. Anderson (\"Anderson\"), a member of the Issuer's board of directors, and Richard A. D'Amore (\"D'Amore\") are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP V-A. Each of NBVM V, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":672513,"source":{"system":"sec-edgar","filing":"0000899243-20-012179","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1138402/000089924320012179/doc4.xml","form_type":"4"}},{"id":3159753,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":112846,"kind":"organization","name":"NBVM GP, LLC","position":1,"cik":"0001401650","reported_name":"NBVM GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46699,"kind":"person","name":"DAMORE RICHARD A","position":2,"cik":"0001206641","reported_name":"DAMORE RICHARD A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112847,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V A LP","position":3,"cik":"0001138402","reported_name":"NORTH BRIDGE VENTURE PARTNERS V A LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112848,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","position":4,"cik":"0001138399","reported_name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112849,"kind":"organization","name":"North Bridge Venture Partners VI L P","position":5,"cik":"0001327539","reported_name":"North Bridge Venture Partners VI L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112850,"kind":"organization","name":"North Bridge Venture Management V, L.P.","position":6,"cik":"0001297397","reported_name":"North Bridge Venture Management V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112851,"kind":"organization","name":"North Bridge Venture Management VI, L.P.","position":7,"cik":"0001590898","reported_name":"North Bridge Venture Management VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-05-06T19:38:21.000Z","date":"2020-05-05","kind":"exercise","acquired":true,"shares":471929,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reportable securities are owned directly by North Bridge Venture Partners VI, L.P. (\"NBVP VI\"). North Bridge Venture Management VI, L.P. (\"NBVM VI\") is the sole general partner of NBVP VI and NBVM GP is the sole general partner of NBVM VI. Each of Anderson, a member of the Issuer's board of directors, and D'Amore are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP VI. Each of NBVM VI, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":471929,"source":{"system":"sec-edgar","filing":"0000899243-20-012179","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1138402/000089924320012179/doc4.xml","form_type":"4"}},{"id":3159752,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":112846,"kind":"organization","name":"NBVM GP, LLC","position":1,"cik":"0001401650","reported_name":"NBVM GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46699,"kind":"person","name":"DAMORE RICHARD A","position":2,"cik":"0001206641","reported_name":"DAMORE RICHARD A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112847,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V A LP","position":3,"cik":"0001138402","reported_name":"NORTH BRIDGE VENTURE PARTNERS V A LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112848,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","position":4,"cik":"0001138399","reported_name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112849,"kind":"organization","name":"North Bridge Venture Partners VI L P","position":5,"cik":"0001327539","reported_name":"North Bridge Venture Partners VI L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112850,"kind":"organization","name":"North Bridge Venture Management V, L.P.","position":6,"cik":"0001297397","reported_name":"North Bridge Venture Management V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112851,"kind":"organization","name":"North Bridge Venture Management VI, L.P.","position":7,"cik":"0001590898","reported_name":"North Bridge Venture Management VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-05-06T19:38:21.000Z","date":"2020-05-05","kind":"exercise","acquired":true,"shares":319303,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reportable securities are owned directly by North Bridge Venture Partners V-B, L.P. (\"NBVP V-B\"). NBVM V is the sole general partner of NBVP V-B and NBVM GP is the sole general partner of NBVM V. Each of Anderson, a member of the Issuer's board of directors, and D'Amore are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP V-B. Each of NBVM V, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":319303,"source":{"system":"sec-edgar","filing":"0000899243-20-012179","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1138402/000089924320012179/doc4.xml","form_type":"4"}},{"id":3159751,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":112846,"kind":"organization","name":"NBVM GP, LLC","position":1,"cik":"0001401650","reported_name":"NBVM GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":46699,"kind":"person","name":"DAMORE RICHARD A","position":2,"cik":"0001206641","reported_name":"DAMORE RICHARD A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112847,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V A LP","position":3,"cik":"0001138402","reported_name":"NORTH BRIDGE VENTURE PARTNERS V A LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112848,"kind":"organization","name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","position":4,"cik":"0001138399","reported_name":"NORTH BRIDGE VENTURE PARTNERS V-B LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112849,"kind":"organization","name":"North Bridge Venture Partners VI L P","position":5,"cik":"0001327539","reported_name":"North Bridge Venture Partners VI L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112850,"kind":"organization","name":"North Bridge Venture Management V, L.P.","position":6,"cik":"0001297397","reported_name":"North Bridge Venture Management V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112851,"kind":"organization","name":"North Bridge Venture Management VI, L.P.","position":7,"cik":"0001590898","reported_name":"North Bridge Venture Management VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-05-06T19:38:21.000Z","date":"2020-05-05","kind":"exercise","acquired":true,"shares":651453,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reportable securities are owned directly by North Bridge Venture Partners V-A, L.P. (\"NBVP V-A\"). North Bridge Venture Management V, L.P. (\"NBVM V\") is the sole general partner of NBVP V-A and North Bridge Venture Management GP, LLC (\"NBVM GP\") is the sole general partner of NBVM V. Each of Edward T. Anderson (\"Anderson\"), a member of the Issuer's board of directors, and Richard A. D'Amore (\"D'Amore\") are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP V-A. Each of NBVM V, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":651453,"source":{"system":"sec-edgar","filing":"0000899243-20-012179","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1138402/000089924320012179/doc4.xml","form_type":"4"}}]}